Regulatory PathRegulatory requirements compared

SFDA item 54 · II. Quality changes · II.5 Drug containing medical device

Change in test procedure of a measuring or administration device for veterinary medicinal products

Variation category under SFDA, EU and US FDA rules for this change, with the variant wording as published.

Open in the Variation Compass

SFDA Saudi Food and Drug Authority

Guidelines for Variation Requirements v6.3 (DS-G-006), item 54 — official PDF, p. 66 ↗

VariantChangeType
aMinor change to an approved test procedureType IA
bOther changes to a test procedure (including replacement or addition)Type IA
cDeletion of a test procedure if an alternative test procedure is already authorizedType IA

Conditions to be fulfilled and documentation to be supplied: see the official guideline, item 54.

EU European Union

Commission Guidelines C/2025/5045 — EUR-Lex ↗

Veterinary medicinal products are outside C/2025/5045, which covers medicinal products for human use. EU veterinary variations follow Regulation (EU) 2019/6 (Articles 60–62) and Implementing Regulation (EU) 2021/17.

US FDA US Food and Drug Administration

21 CFR 314.70 and FDA guidance — Not covered by 21 CFR 314.70 (veterinary; FDA CVM, 21 CFR 514.8)

ChangeCategoryReference
Any test-procedure change for a veterinary deviceNo US equivalent

Note: Not covered by 21 CFR 314.70 (human drugs, NDA/ANDA); veterinary products fall under FDA CVM rules (21 CFR 514.8).

Other items in II.5 Drug containing medical device

Not regulatory advice. The binding text is each regulator's current official document; confirm the category with the authority before filing. FDA publishes no classification table: the US category follows FDA guidance or, where the guidance does not name the change, the closest example under 21 CFR 314.70.